Notice of NIGMS Participation in PAR-23-219 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)"
Notice Number:
NOT-GM-23-051

Key Dates

Release Date:

September 7, 2023

Related Announcements

  • July 12, 2023 - SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed). See NOFO PAR-23-219.

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of General Medical Sciences (NIGMS) is participating, effective immediately, in PAR-23-219 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)."

The following sections have been updated to reflect the participation of NIGMS in this NOFO. Changes are noted in bold italic text. 

Part 1. Overview Information

Components of Participating Organizations

Office of The Director, National Institutes of Health (OD)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Center for Advancing Translational Sciences (NCATS)

National Cancer Institute (NCI)

Assistance Listing Number

93.847, 93.867, 93.853, 93.838, 93.855, 93.837, 93.839, 93.840, 93.233, 93.172, 93.273, 93.394, 93.395, 93.286, 93.242, 93.846, 93.350, 93.173, 93.113, 93.121, 93.859

The following sections have also been updated to provide information about NIGMS' interests and contact information.

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description 

National Institute of General Medical Sciences (NIGMS)

NIGMS is interested in CRP applications from NIGMS Phase II and Phase IIB SBIR-funded applicants that are within the NIGMS mission. NIGMS will consider awards up to $1,000,000 total costs (direct costs, indirect costs, fee) per year for up to 3 years.  Potential applicants are strongly encouraged to contact the NIGMS Scientific/Research Contact listed below. .

Section VII. Agency Contacts 

Scientific/Research Contact(s)

Eddie Billingslea
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]

Financial/Grants Management Contact(s)

Brian Iglesias
National Institute of General Medical Sciences
Email: [email protected]

All other aspects of the NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Eddie Billingslea
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]